Annual CFF
$196.25 M
+$178.73 M+1020.20%
December 31, 2023
Summary
- As of February 12, 2025, BLUE annual cash flow from financing activities is $196.25 million, with the most recent change of +$178.73 million (+1020.20%) on December 31, 2023.
- During the last 3 years, BLUE annual CFF has fallen by -$350.47 million (-64.10%).
- BLUE annual CFF is now -81.76% below its all-time high of $1.08 billion, reached on December 31, 2017.
Performance
BLUE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$6.11 M
-$44.00 K-0.73%
September 30, 2024
Summary
- As of February 12, 2025, BLUE quarterly cash flow from financing activities is -$6.11 million, with the most recent change of -$44.00 thousand (-0.73%) on September 30, 2024.
- Over the past year, BLUE quarterly CFF has dropped by -$70.75 million (-109.44%).
- BLUE quarterly CFF is now -100.93% below its all-time high of $658.79 million, reached on September 30, 2018.
Performance
BLUE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$159.06 M
+$5.73 M+3.74%
September 30, 2024
Summary
- As of February 12, 2025, BLUE TTM cash flow from financing activities is $159.06 million, with the most recent change of +$5.73 million (+3.74%) on September 30, 2024.
- Over the past year, BLUE TTM CFF has increased by +$13.34 million (+9.15%).
- BLUE TTM CFF is now -87.99% below its all-time high of $1.32 billion, reached on September 30, 2018.
Performance
BLUE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BLUE Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1020.2% | -109.4% | +9.2% |
3 y3 years | -64.1% | +83.4% | +807.9% |
5 y5 years | -73.4% | -246.1% | +2231.5% |
BLUE Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +308.9% | -105.3% | +96.5% | -18.9% | +232.9% |
5 y | 5-year | -64.1% | +308.9% | -101.1% | +96.5% | -71.1% | +232.9% |
alltime | all time | -81.8% | +308.9% | -100.9% | +96.5% | -88.0% | +232.9% |
Bluebird Bio Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$6.11 M(+0.7%) | $159.06 M(+3.7%) |
Jun 2024 | - | -$6.06 M(-109.4%) | $153.32 M(+5.2%) |
Mar 2024 | - | $64.64 M(-39.3%) | $145.72 M(-25.7%) |
Dec 2023 | $196.25 M(+1020.2%) | $106.58 M(-1000.4%) | $196.25 M(+271.5%) |
Sep 2023 | - | -$11.84 M(-13.4%) | $52.82 M(-52.4%) |
Jun 2023 | - | -$13.67 M(-111.9%) | $110.98 M(-16.4%) |
Mar 2023 | - | $115.18 M(-412.6%) | $132.69 M(+657.4%) |
Dec 2022 | $17.52 M(-118.6%) | -$36.85 M(-179.5%) | $17.52 M(-114.6%) |
Sep 2022 | - | $46.33 M(+476.6%) | -$119.65 M(+32.8%) |
Jun 2022 | - | $8.03 M(>+9900.0%) | -$90.10 M(-7.8%) |
Mar 2022 | - | $9000.00(-100.0%) | -$97.74 M(+4.0%) |
Dec 2021 | -$93.95 M(-117.2%) | -$174.01 M(-329.4%) | -$93.95 M(-215.3%) |
Sep 2021 | - | $75.87 M(>+9900.0%) | $81.49 M(+1094.5%) |
Jun 2021 | - | $396.00 K(-89.6%) | $6.82 M(-98.8%) |
Mar 2021 | - | $3.80 M(+165.1%) | $549.55 M(+0.5%) |
Dec 2020 | $546.72 M(+2480.4%) | $1.43 M(+19.5%) | $546.72 M(-0.1%) |
Sep 2020 | - | $1.20 M(-99.8%) | $547.29 M(-0.5%) |
Jun 2020 | - | $543.12 M(>+9900.0%) | $550.27 M(+4513.6%) |
Mar 2020 | - | $963.00 K(-52.0%) | $11.93 M(-43.7%) |
Dec 2019 | $21.19 M(-97.1%) | $2.00 M(-52.0%) | $21.19 M(+0.4%) |
Sep 2019 | - | $4.18 M(-12.6%) | $21.10 M(-96.9%) |
Jun 2019 | - | $4.78 M(-53.2%) | $675.72 M(-0.1%) |
Mar 2019 | - | $10.22 M(+432.2%) | $676.24 M(-8.3%) |
Dec 2018 | $737.69 M | $1.92 M(-99.7%) | $737.69 M(-44.3%) |
Sep 2018 | - | $658.79 M(>+9900.0%) | $1.32 B(+97.2%) |
Jun 2018 | - | $5.30 M(-92.6%) | $671.43 M(-40.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $71.68 M(-87.8%) | $1.13 B(+5.1%) |
Dec 2017 | $1.08 B(+345.6%) | $588.33 M(+9513.3%) | $1.08 B(+47.9%) |
Sep 2017 | - | $6.12 M(-98.7%) | $727.62 M(+0.5%) |
Jun 2017 | - | $464.85 M(+2655.3%) | $723.93 M(+180.8%) |
Mar 2017 | - | $16.87 M(-93.0%) | $257.77 M(+6.7%) |
Dec 2016 | $241.53 M(-50.4%) | $239.77 M(+9755.0%) | $241.53 M(+8594.5%) |
Sep 2016 | - | $2.43 M(-285.6%) | $2.78 M(-17.0%) |
Jun 2016 | - | -$1.31 M(-305.2%) | $3.35 M(-99.3%) |
Mar 2016 | - | $639.00 K(-37.2%) | $484.89 M(-0.4%) |
Dec 2015 | $486.72 M(+35.8%) | $1.02 M(-66.1%) | $486.72 M(-33.5%) |
Sep 2015 | - | $3.00 M(-99.4%) | $732.01 M(-12.8%) |
Jun 2015 | - | $480.24 M(>+9900.0%) | $839.26 M(+133.0%) |
Mar 2015 | - | $2.46 M(-99.0%) | $360.25 M(+0.5%) |
Dec 2014 | $358.45 M(+239.3%) | $246.31 M(+123.4%) | $358.45 M(+219.0%) |
Sep 2014 | - | $110.25 M(+8899.6%) | $112.37 M(>+9900.0%) |
Jun 2014 | - | $1.23 M(+82.6%) | $948.00 K(-99.1%) |
Mar 2014 | - | $671.00 K(+188.0%) | $106.69 M(+1.0%) |
Dec 2013 | $105.64 M(+76.5%) | $233.00 K(-119.7%) | $105.64 M(+0.2%) |
Sep 2013 | - | -$1.18 M(-101.1%) | $105.39 M(-36.7%) |
Jun 2013 | - | $106.97 M(<-9900.0%) | $166.43 M(+179.9%) |
Mar 2013 | - | -$381.00 K(+2440.0%) | $59.47 M(-0.6%) |
Dec 2012 | $59.85 M(+84.5%) | -$15.00 K(-100.0%) | $59.85 M(-0.0%) |
Sep 2012 | - | $59.86 M(>+9900.0%) | $59.87 M(>+9900.0%) |
Jun 2012 | - | $8000.00(>+9900.0%) | $8000.00(>+9900.0%) |
Mar 2012 | - | $0.00 | $0.00 |
Dec 2011 | $32.44 M | - | - |
FAQ
- What is bluebird bio annual cash flow from financing activities?
- What is the all time high annual CFF for bluebird bio?
- What is bluebird bio annual CFF year-on-year change?
- What is bluebird bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for bluebird bio?
- What is bluebird bio quarterly CFF year-on-year change?
- What is bluebird bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for bluebird bio?
- What is bluebird bio TTM CFF year-on-year change?
What is bluebird bio annual cash flow from financing activities?
The current annual CFF of BLUE is $196.25 M
What is the all time high annual CFF for bluebird bio?
bluebird bio all-time high annual cash flow from financing activities is $1.08 B
What is bluebird bio annual CFF year-on-year change?
Over the past year, BLUE annual cash flow from financing activities has changed by +$178.73 M (+1020.20%)
What is bluebird bio quarterly cash flow from financing activities?
The current quarterly CFF of BLUE is -$6.11 M
What is the all time high quarterly CFF for bluebird bio?
bluebird bio all-time high quarterly cash flow from financing activities is $658.79 M
What is bluebird bio quarterly CFF year-on-year change?
Over the past year, BLUE quarterly cash flow from financing activities has changed by -$70.75 M (-109.44%)
What is bluebird bio TTM cash flow from financing activities?
The current TTM CFF of BLUE is $159.06 M
What is the all time high TTM CFF for bluebird bio?
bluebird bio all-time high TTM cash flow from financing activities is $1.32 B
What is bluebird bio TTM CFF year-on-year change?
Over the past year, BLUE TTM cash flow from financing activities has changed by +$13.34 M (+9.15%)